Literature DB >> 2565378

Dual labelling of circulating CD8 cells in patients with multiple sclerosis.

P J Hughes1, P F Kirk, D A Compston.   

Abstract

Peripheral blood T cell phenotypes have been analysed in serial samples from patients with multiple sclerosis, their unaffected relatives and controls using a panel of antibodies chosen to distinguish T suppressor and activated suppressor cells from other CD8 lymphocytes. Overall, the percentage of Leu 2a cells correlated with alterations in the Leu 2a/15 suppressor sub-population (r = 0.79, p less than 0.001). Fewer circulating Leu 2a and Leu 2a/15 positive cells were identified in multiple sclerosis patients than unaffected individuals but there was no alteration in percentage of activated (Leu 2a/DR) CD8 cells. These findings suggest that the fluctuations in CD8 cells, characteristic of patients with multiple sclerosis, are due to alterations in T suppressor phenotype; this may then lower the threshold for activation of other T cell subpopulations.

Entities:  

Mesh:

Year:  1989        PMID: 2565378      PMCID: PMC1032670          DOI: 10.1136/jnnp.52.1.118

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  30 in total

1.  Antigen reactive memory T cells are defined by Ta1.

Authors:  D A Hafler; D A Fox; D Benjamin; H L Weiner
Journal:  J Immunol       Date:  1986-07-15       Impact factor: 5.422

2.  Multiple sclerosis: increased expression of interleukin-2 receptors on lymphocytes.

Authors:  K Selmaj; C Plater-Zyberk; K A Rockett; R N Maini; R Alam; G D Perkin; F C Rose
Journal:  Neurology       Date:  1986-10       Impact factor: 9.910

3.  Suppressor T cell changes in active multiple sclerosis: analysis with three different monoclonal antibodies.

Authors:  A J Thompson; J Brazil; E A Martin; M Hutchinson; C A Whelan; C Feighery
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-10       Impact factor: 10.154

4.  Peripheral blood lymphocyte phenotype and function in multiple sclerosis.

Authors:  P J Hughes; D A Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-09       Impact factor: 10.154

5.  IL-2 receptor and HLA class II antigens on cerebrospinal fluid cells of patients with multiple sclerosis and other neurological diseases.

Authors:  E Tournier-Lasserve; O Lyoncaen; E Roullet; M A Bach
Journal:  Clin Exp Immunol       Date:  1987-03       Impact factor: 4.330

6.  Normal T cell subsets and lymphocyte activity in multiple sclerosis.

Authors:  M M Albala; D Davignon; L D Fast; D D Clark
Journal:  Clin Exp Immunol       Date:  1985-09       Impact factor: 4.330

7.  Deficit of suppressor T cells in active multiple sclerosis.

Authors:  M A Bach; F Phan-Dinh-Tuy; E Tournier; L Chatenoud; J F Bach; C Martin; J D Degos
Journal:  Lancet       Date:  1980-12-06       Impact factor: 79.321

8.  Selective loss of the suppressor-inducer T-cell subset in progressive multiple sclerosis. Analysis with anti-2H4 monoclonal antibody.

Authors:  C Morimoto; D A Hafler; H L Weiner; N L Letvin; M Hagan; J Daley; S F Schlossman
Journal:  N Engl J Med       Date:  1987-01-08       Impact factor: 91.245

9.  Suppressor T cells in family members of patients with multiple sclerosis.

Authors:  P J Hughes; P F Kirk; D A Compston
Journal:  Brain       Date:  1986-10       Impact factor: 13.501

10.  Activated suppressor cell dysfunction in progressive multiple sclerosis.

Authors:  J P Antel; M B Bania; A Reder; N Cashman
Journal:  J Immunol       Date:  1986-07-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.